ACOM Labs
Innovative device-enabled therapeutics for at-home dermatological care
United States · $25.0M raised
- Employees
- 1–10
- Business Model
- B2B
- Total Funding
- $25.0M
- Last Round
- $25.0M Series AOct 2025
- Rounds
- 1
About
ACOM Labs, doing business as Indomo, is a clinical-stage therapeutics company dedicated to expanding access to quality healthcare through innovative device-enabled drug delivery. The company is developing DT-001, a drug-device combination candidate that pairs triamcinolone acetonide with the ClearPen™ — a novel intradermal self-injection device — to enable fast-acting at-home treatment of inflammatory acne lesions. Indomo's model transforms in-office dermatological procedures into self-administered patient care, addressing limited access to clinic-based treatments.
Summary
ACOM Labs is a Biotech company based in United States. It has raised $25.0M in total across 1 round, most recently a $25.0M Series A round in Oct 2025. Investors include Atomic, Foresite Capital and Polaris Partners.
Funding History
Oct 2025
Investors
Similar Companies
China's leading blood products manufacturer
IVI-RMA provides fertility treatments and patient-centered reproductive care, combining research,...
Altos Labs combines academic science and industry development to create medicines that restore ce...
inVentiv Health merged with INC Research to form Syneos Health, integrating clinical and commerci...
Specialty pharmaceutical company
BeOne Medicines develops transformative oncology medicines through rigorous science, an accelerat...
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/acom-labs"><img src="https://indexed.vc/api/badge/company/acom-labs" alt="ACOM Labs on Indexed.vc" width="260" height="76" /></a>